Complete pathological response is predictive for clinical outcome after tri-modality therapy for carcinomas of the superior pulmonary sulcus

Virchows Archiv

Volumn 462, Issue 5, 2013, Pages 547-556

  Blaauwgeers, Johannes L ^a   Kappers, Ingrid ^b   Klomp, Houke M ^b   Belderbos, José S ^b   Dijksman, Lea M ^a   Smit, Egbert F ^c   Postmus, Pieter E ^c   Paul, Marinus A ^c   Oosterhuis, Jan W ^c   Hartemink, Koen J ^c   Vos, Cornelis G ^c   Burgers, Jacobus A ^b   Dahele, Max ^c   Phernambucq, Erik C ^c   Witte, Birgit I ^c   Thunnissen, Erik ^c  

^a Onze Lieve Vrouwe Gasthuis ^*  (Netherlands)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Chemoradiation; Histopathology; Lung cancer; Pancoast; Prognosis

Indexed keywords

CISPLATIN; GEMCITABINE; ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CHEMORADIOTHERAPY; CLINICAL ARTICLE; CLINICAL FEATURE; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; HUMAN TISSUE; LARGE CELL CARCINOMA; LUNG ADENOCARCINOMA; LUNG CARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MALE; MULTIMODALITY CANCER THERAPY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PREDICTION; PRIORITY JOURNAL; RADIATION DOSE; RETROSPECTIVE STUDY; STAGING; TREATMENT RESPONSE; TUMOR CELL; KAPLAN MEIER METHOD; LUNG RESECTION; MIDDLE AGED; MORTALITY; PANCOAST TUMOR; PATHOLOGY; PROGNOSIS; RADIOTHERAPY; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC AGENTS; CARCINOMA, NON-SMALL-CELL LUNG; COMBINED MODALITY THERAPY; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PANCOAST SYNDROME; PNEUMONECTOMY; PROGNOSIS; RADIOTHERAPY; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

MLCS; MLOWN;

EID: 84879298332     PISSN: 09456317     EISSN: 14322307     Source Type: Journal    
DOI: 10.1007/s00428-013-1404-6     Document Type: Article

References (23)

1. Chansky K, Sculier J-P, Crowley JJ, Giroux D, van Meerbeeck J, Goldstraw P (2009) The International Association for the Study of Lung Cancer staging project. Prognostic factors and pathologic TNM stage in surgically managed non small cell lung cancer. J Thor Oncol 4:729-801
2. Takeda S, Maeda H, Okada T, Yamaguchi T, Nakagawa M, Yokota S, Sawabata N, Ohta M (2006) Results of pulmonary resection following neoadjuvant therapy for locally advanced (IIIA-IIIB) lung cancer. Eur J Cardiothorac Surg 30:184-189
3. Caglar HB, Baldini EH, Othus M, Rabin MS, Bueno R, Sugarbaker DJ, Mentzer SJ, Jänne PA, Johnson BE, Allen AM (2009) Outcomes of patients with stage III non small cell lung cancer treated with chemotherapy and radiation with and without surgery. Cancer 115:4156-4166
4. Kappers I, van Sandick JW, Burgers JA, Belderbos JS, Wouters MW, van Zandwijk N, Klomp HM (2009) Results of combined modality treatment in patients with non-small-cell lung cancer of the superior sulcus and the rationale for surgical resection. Eur J Cardiothorac Surg 36:741-746
5. Peedell C, Dunning J, Bapusamy A (2010) Is there a standard of care for the radical management of non-small cell lung cancer involving the apical chest wall (Pancoast tumours)? Clin Oncol 22:334-346
6. Pourel N, Santelmo N, Naafa N, Serre A, Hilgers W, Mineur L, Molinari N, Reboul F (2008) Concurrent cisplatin/etoposide plus 3D-conformal radiotherapy followed by surgery for stage IIB (superior sulcus T3N0)/III non-small cell lung cancer yields a high rate of pathological complete response. Eur J Cardiothorac Surg 33:829-836
7. Rusch VW, Giroux DJ, Kraut MJ, Crowley J, Hazuka M, Winton T, Johnson DH, Shulman L, Shepherd F, Deschamps C, Livingston RB, Gandara D (2007) Induction chemoradiation and surgical resection for superior sulcus non-small-cell lung carcinomas: long-term results of Southwest Oncology Group Trial 9416 (Intergroup Trial 0160). J Clin Oncol 25:313-318
8. Junker K, Thomas M, Schulmann K, Klinke F, Bosse U, Müller KM (1997) Tumour regression in non-small-cell lung cancer following neoadjuvant therapy. Histological assessment. J Cancer Res Clin Oncol 123:469-477
9. Liu-Jarin X, Stoopler MB, Raftopoulos H, Ginsburg M, Gorenstein L, Borczuk AC (2003) Histologic assessment of non-small cell lung carcinoma after neoadjuvant therapy. Mod Pathol 16:1102-1108
10. Yamane Y, Ishii G, Goto K, Kojima M, Nakao M, Shimada Y, Nishiwaki Y, Nagai K, Kohrogi H, Ochiai A (2010) A novel histopathological evaluation method predicting the outcome of non-small cell lung cancer treated by neoadjuvant therapy. The prognostic importance of the area of residual tumor. J Thor Oncol 5:49-55
11. Detterbeck FC (2003) Changes in the treatment of Pancoast tumors. Ann Thorac Surg 75:1990-1997
12. Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S, Mooney M, Rubinstein L, Shankar L, Dodd L, Kaplan R, Lacombe D, Verweij J (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45:228-247
13. Curtin F, Schulz P (1998) Multiple correlations and Bonferroni's correction. Biol Psychiatry 44:775-777
14. Thunnissen FB, Schuurbiers OC, den Bakker MA (2006) A critical appraisal of prognostic and predictive factors for common lung cancers. Histopathology 48(7):779-786
15. Fischer S, Darling G, Pierre AF, Sun A, Leighl N, Waddell TK, Keshavjee S, de Perrot M (2008) Induction chemoradiation therapy followed by surgical resection for non-small cell lung cancer (NSCLC) invading the thoracic inlet. Eur J Cardiothorac Surg 33:1129-1134
16. Dworak O, Keilholz L, Hoffmann A (1997) Pathological features of rectal cancer after preoperative radiochemotherapy. Int J Colorectal Dis 12:19-23
17. Bollschweiler E, Metzger R, Drebber U, Baldus S, Vallböhmer D, Kocher M, Hölscher AH (2009) Histological type of esophageal cancer might affect response to neo-adjuvant radiochemotherapy and subsequent prognosis. Ann Oncol 20:231-238
18. Harrison L, Blackwell K (2004) Hypoxia and anemia: factors in decreased sensitivity to radiation therapy and chemotherapy? Oncologist 9(Suppl 5):31-40
19. Brown JM (2002) Tumor microenvironment and the response to anticancer therapy. Cancer Biol Ther 1:453-458
20. Brambilla E, Travis WD, Colby TV, Corrin B, Shimosato Y (2001) The new World Health Organization classification of lung tumours. Eur Respir J 18:1059-1068
21. Rami-Porta R, Crowley JJ, Goldstraw P (2009) The revised TNM staging system for lung cancer. Ann Thorac Cardiovasc Surg 15:4-9
22. Goldstraw P (2009) The IASLC staging manual in thoracic oncology. Editorial Rx, Orange Park, pp 37-38
23. Becker K, Mueller JD, Schulmacher C, Ott K, Fink U, Busch R, Böttcher K, Siewert JR, Höfler H (2003) Histomorphology and grading of regression in gastric carcinoma treated with neoadjuvant chemotherapy. Cancer 98(7):1521-1530